Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2021 | 33816236 | PubTator, text mining | PubMed |
| The interplay between airway epithelium and the immune system - A primer for the respiratory clinician. | Paediatr Respir Rev | 2021 | 33812796 | PubTator, text mining | PubMed |
| Progression of Metastasis through Lymphatic System. | Cells | 2021 | 33808959 | PubTator, text mining | PubMed |
| Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias. | Cancers (Basel) | 2021 | 33801964 | PubTator, text mining | PubMed |
| Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis. | Aging (Albany NY) | 2021 | 33795528 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. | Immunity | 2021 | 33789089 | PubTator, text mining | PubMed |
| DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer. | Onco Targets Ther | 2021 | 33776450 | PubTator, text mining | PubMed |
| Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation. | NPJ Precis Oncol | 2021 | 33772139 | PubTator, text mining | PubMed |
| Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma. | Front Oncol | 2021 | 33767990 | PubTator, text mining | PubMed |
| Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models. | Cancer Res | 2021 | 33757978 | PubTator, text mining | PubMed |
| Tissue-resident memory T cells in tumor immunity and immunotherapy. | J Exp Med | 2021 | 33755718 | PubTator, text mining | PubMed |
| Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. | Stem Cell Res Ther | 2021 | 33736695 | PubTator, text mining | PubMed |
| A Potential Role of Group 2 Innate Lymphoid Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps. | Allergy Asthma Immunol Res | 2021 | 33733633 | PubTator, text mining | PubMed |
| ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma. | Front Genet | 2021 | 33732282 | PubTator, text mining | PubMed |
| Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes. | PLoS Pathog | 2021 | 33720992 | PubTator, text mining | PubMed |
| TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion. | Aging (Albany NY) | 2021 | 33714201 | PubTator, text mining | PubMed |
| ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors. | BMC Cancer | 2021 | 33711961 | PubTator, text mining | PubMed |
| SARS-CoV-2 and the Gastrointestinal Tract in Children. | Front Pediatr | 2021 | 33692973 | PubTator, text mining | PubMed |
| CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment. | Front Oncol | 2021 | 33692955 | PubTator, text mining | PubMed |
| Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial. | PLoS One | 2021 | 33690665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=53